Skip to main content
ArticleOPEN ACCESS

Drug resistance in malaria

British Medical Bulletin
DOI: 10.1093/oxfordjournals.bmb.a011721
142Citations
Citations of this article
67Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Drug resistance in malaria is now widespread and in many parts of the world is making treatment increasingly difficult. This article reviews current knowledge of the mechanisms and extent of resistance of Plasmodium falciparum and P. vivax to the available antimalarial drugs, and the recommendations for treating malaria in regions where resistance is prevalent.

Cited by Powered by Scopus

Medical need, scientific opportunity and the drive for antimalarial drugs

Nature
728Citations
N/AReaders
Get full text

Global Change and Human Vulnerability to Vector-Borne Diseases

Clinical Microbiology Reviews
489Citations
N/AReaders
Get full text

Characterization of native and recombinant falcipain-2, a principal trophozoite cysteine protease and essential hemoglobinase of Plasmodium falciparum

Journal of Biological Chemistry
333Citations
N/AReaders
Get full text
View more at Scopus

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

White, N. J. (1998). Drug resistance in malaria. British Medical Bulletin. Royal Society of Medicine Press Ltd. https://doi.org/10.1093/oxfordjournals.bmb.a011721

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 33

70%

Researcher 8

17%

Professor / Associate Prof. 6

13%

Readers' Discipline

Tooltip

Agricultural and Biological Sciences 20

43%

Medicine and Dentistry 12

26%

Chemistry 7

15%

Biochemistry, Genetics and Molecular Bi... 7

15%

Save time finding and organizing research with Mendeley

Sign up for free